Companies need to show that they have the expertise to build reliable AI technologies that deliver on promises and achieve tangible results. For instance, a BCG survey conducted in April 2024 revealed that 20% of cardiologists do not adopt digital tools due to the lack of sufficient insights to support comprehensive clinical decision- making. This highlights the need for businesses to ensure that their AI solutions meet the high standards required by health professionals. Reliability, marked by consistent performance and dependability, is vital to meet expectations and fulfil commitments. Businesses also need to show benevolence – genuine care for the interests and well-being of others. By acting with the best interests of patients, providers and other stakeholders in mind, companies can promote positive relationships and build trust. Lastly, shared values between businesses and their stakeholders are essential. Mutual understanding and agreement on core principles provide a solid foundation for collaboration and acceptance of AI technologies. Contrasting consumer sentiments challenging AI adoption in global markets FIGURE 7 Notes: Net excitement = % excited minus % concerned. Source: BCG. (2023). Consumers know more about AI than business leaders think. https://www.bcg.com/publications/2024/consumers-know-more-about-ai-than-businesses-thinkE xcited C onﬂicted C oncerned % attitudes to AINet excitement918 16 15191122 2217 19 1824 20 203040 39 42 4350 49 3533 41 43 37 53 32 3542 33 43 46 46 44312730 28 2521 24564944 42 443646 4437 37 384338 36 3934 31 30 31 29 26UKChina Indonesia Thailand Saudi A rabia Mexic o India Brazil UAE Philippines Türkiye Argentina South A fricaMorocco Japan Germany Sweden France AustraliaUSSouth Korea47% 31% 29% 24% 25% 25% 26% 20% 20% 22% 19% 19% -21% 18% 16% -5% -10% -12% -23% -11% 9%Most excited Most concerned Adoption hinges on strong trust but agile regulation and governance Advancing AI in healthcare requires a balanced approach that promotes trust, collaboration and regulatory agility. Establishing flexible regulatory frameworks, integrating human oversight and ensuring transparency are essential to addressing public concerns and building confidence in AI technologies. Both public and private stakeholders have a role in developing adaptable guidelines and standards that keep pace with AI advances. Additionally, promoting data-sharing while protecting privacy and encouraging sustainable business models can enhance AI’s impact on health. By aligning strategies and maintaining a focus on ethics and public good, AI can be confidently used to improve global healthcare outcomes. i The Future of AI-Enabled Health: Leading the Way 22

The Future of AI Enabled Health 2025